Page 5 note on peer reviews for OA008:
"These results have been written up astwo manuscripts and submitted toleading journals for peer review. The firstmanuscript details the outcomes of thePARA_OA_008 Phase 2 trial and thesecond manuscript compares thePARA_OA_008 results to currentlyavailable and pipeline therapies forosteoarthritis. Peer-reviewed publicationsplay a critical role in establishing scientificcredibility, enhancing visibility within themedical community, and providingvalidation of the clinical data underpinning our program"
Ann: Appendix 4D and Half Year Report, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
32.5¢ |
Change
0.035(12.1%) |
Mkt cap ! $126.5M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 33.5¢ | 29.0¢ | $692.3K | 2.176M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 11161 | 32.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.0¢ | 134295 | 1 |
View Market Depth
| Last trade - 16.10pm 24/06/2025 (20 minute delay) ? |
| PAR (ASX) Chart |